Abstract:The influence of miRNA‐1225‐5p (miR‐1225) and Keap1‐Nrf2 signalling on in vitro osteoclast differentiation in mouse models was studied along with the underlying mechanism. In differentiated bone marrow–derived macrophages (BMMs), downregulated miR‐1225 and upregulated Keap1 were observed in the course of receptor activator of nuclear factor kappa‐Β ligand (RANKL)–mediated osteoclastogenesis. Bioinformatic analysis and dual‐luciferase reporter assay showed that miR‐1225 targeted the three prime untranslated region (3′‐UTR) of Keap1 mRNA and caused its degradation. Transfection of a miR‐1225 mimic or Keap1 silencing was found to inhibit osteoclastogenesis as evidenced by loss of activity and tartrate‐resistant acid phosphatase (TRAP) staining, decreased expression of osteoclast markers, and associated genes and reduced number of multinuclear cells; in contrast, a miR‐1225 inhibitor or Keap1 overexpression increased this process. In addition, transfection with the miR‐1225 mimic or Keap1 silencing decreased the level of tumour necrosis factor (TNF)α, which was increased after miR‐1225 inhibition and Keap1 overexpression. TNFα overexpression promoted Keap1 depletion–inhibited BMM osteoclastogenesis. Furthermore, reactive oxygen species (ROS) generation that is related to osteoclastogenesis and the Keap‐Nrf2 axis was impaired by the miR‐1225 mimic and Keap1 silencing, whereas it was increased following miR inhibition and overexpression of Keap1 and TNFα. Thus, miR‐1225 inhibits osteoclastogenesis by directly activating the Keap1‐Nrf2‐HO‐1 axis to repress TNFα‐mediated ROS generation.Our study showed that miR‐1225 is significant in multiple malignancies and other pathological reactions. Transfection of a miR‐1225 mimic or Keap1 silencing inhibits osteoclastogenesis. After miR‐1225 inhibition and Keap1 overexpression, TNF was increased. TNFα overexpression promoted Keap1 depletion–inhibited BMM osteoclastogenesis. miR‐1225 activates Keap1‐Nrf2‐HO‐1 signal to inhibit TNFα‐induced osteoclastogenesis.

Mir-1228 Prevents Cellular Apoptosis Through Targeting of MOAP1 Protein

MicroRNA‐122 Suppresses Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma by Directly Targeting Wnt/β‐catenin Pathway

Restoration Of Mir-1228*Expression Suppresses Epithelial-Mesenchymal Transition In Gastric Cancer

Mir-92A Inhibits Vascular Smooth Muscle Cell Apoptosis: Role of the MKK4–JNK Pathway

Upregulation of Mirna-1228-3p Alleviates TGF-β-induced Fibrosis in Renal Tubular Epithelial Cells.

Mir-433 Inhibits Breast Cancer Cell Growth Via the MAPK Signaling Pathway by Targeting Rap1a

Mirna-214 Inhibits Cellular Proliferation and Migration in Glioma Cells Targeting Caspase 1 Involved in Pyroptosis.

Mir-124 Downregulates Bace 1 and Alters Autophagy in App/Ps1 Transgenic Mice

Mir-182 Induces Cervical Cancer Cell Apoptosis Through Inhibiting the Expression of DNMT3a.

Mir-322 Treatment Rescues Cell Apoptosis and Neural Tube Defect Formation Through Silencing NADPH Oxidase 4.

Mir-145-5p Inhibits Epithelial-Mesenchymal Transition Via the JNK Signaling Pathway by Targeting MAP3K1 in Non-Small Cell Lung Cancer Cells.

MicroRNA-124-mediated regulation of inhibitory member of apoptosis-stimulating protein of p53 family in experimental stroke

Effects of Mirnas on Myocardial Apoptosis by Modulating Mitochondria Related Proteins

MiRNA-122-5p inhibitor abolishes angiotensin II–mediated loss of autophagy and promotion of apoptosis in rat cardiofibroblasts by modulation of the apelin-AMPK-mTOR signaling

Nuclear Mir-122 Directly Regulates the Biogenesis of Cell Survival Oncomir Mir-21 at the Posttranscriptional Level.

MicroRNA-23a/b and Microrna-27A/b Suppress Apaf-1 Protein and Alleviate Hypoxia-Induced Neuronal Apoptosis

Mir-512-5p Induces Apoptosis and Inhibits Glycolysis by Targeting P21 in Non-Small Cell Lung Cancer Cells

Downregulation Of Mir-34a Attenuates Myocardial Ischemia/Reperfusion Injury By Inhibiting Cardiomyocyte Apoptosis

Mir-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity

Mir‐34a Inhibits the Apoptosis of MDSCs by Suppressing the Expression of N‐myc

MicroRNA‐1225 activates Keap1‐Nrf2‐HO‐1 signalling to inhibit TNFα‐induced osteoclastogenesis by mediating ROS generation